• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Predicting Egg Passage Adaptations to Design Better Vaccines for the H3N2 Influenza Virus

tetano

Editor, Senior Moderator
Viruses


. 2022 Sep 17;14(9):2065.
doi: 10.3390/v14092065.
Predicting Egg Passage Adaptations to Design Better Vaccines for the H3N2 Influenza Virus


Yunsong Liu[SUP] 1 2 [/SUP], Hui Chen[SUP] 3 [/SUP], Wenyuan Duan[SUP] 1 2 [/SUP], Xinyi Zhang[SUP] 1 2 [/SUP], Xionglei He[SUP] 4 [/SUP], Rasmus Nielsen[SUP] 5 6 7 [/SUP], Liang Ma[SUP] 1 [/SUP], Weiwei Zhai[SUP] 1 2 8 [/SUP]



Affiliations

Abstract

Seasonal H3N2 influenza evolves rapidly, leading to an extremely poor vaccine efficacy. Substitutions employed during vaccine production using embryonated eggs (i.e., egg passage adaptation) contribute to the poor vaccine efficacy (VE), but the evolutionary mechanism remains elusive. Using an unprecedented number of hemagglutinin sequences (n = 89,853), we found that the fitness landscape of passage adaptation is dominated by pervasive epistasis between two leading residues (186 and 194) and multiple other positions. Convergent evolutionary paths driven by strong epistasis explain most of the variation in VE, which has resulted in extremely poor vaccines for the past decade. Leveraging the unique fitness landscape, we developed a novel machine learning model that can predict egg passage substitutions for any candidate vaccine strain before the passage experiment, providing a unique opportunity for the selection of optimal vaccine viruses. Our study presents one of the most comprehensive characterizations of the fitness landscape of a virus and demonstrates that evolutionary trajectories can be harnessed for improved influenza vaccines.

Keywords: H3N2 influenza; convergent evolution; epistasis; fitness landscape; passage adaptation; vaccine efficacy.
 
Back
Top Bottom